Cargando…
Pathomechanisms and Clinical Implications of Myasthenic Syndromes Exacerbated and Induced by Medical Treatments
Myasthenic syndromes are typically characterized by muscle weakness and increased fatigability due to an impaired transmission at the neuromuscular junction (NMJ). Most cases are caused by acquired autoimmune conditions such as myasthenia gravis (MG), typically with antibodies against the acetylchol...
Autores principales: | Krenn, Martin, Grisold, Anna, Wohlfarth, Philipp, Rath, Jakob, Cetin, Hakan, Koneczny, Inga, Zimprich, Fritz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457047/ https://www.ncbi.nlm.nih.gov/pubmed/32922263 http://dx.doi.org/10.3389/fnmol.2020.00156 |
Ejemplares similares
-
Cerebrospinal fluid analysis in Guillain–Barré syndrome: value of albumin quotients
por: Rath, Jakob, et al.
Publicado: (2021) -
Real-world treatment of adult patients with Guillain-Barré syndrome over the last two decades
por: Rath, Jakob, et al.
Publicado: (2021) -
Severe Myasthenic Manifestation of Leptospirosis Associated with New Sequence Type of Leptospira interrogans
por: Tomschik, Matthias, et al.
Publicado: (2019) -
The clinical and molecular landscape of congenital myasthenic syndromes in Austria: a nationwide study
por: Krenn, Martin, et al.
Publicado: (2022) -
Frequency and clinical features of treatment-refractory myasthenia gravis
por: Rath, Jakob, et al.
Publicado: (2019)